Akouos
PublicLast Round
M&A
Oct 18, 2022
Est. Valuation
$610M
Total Funding Raised
$893.97M
Company Overview
Akouos (NAS: AKUS) is a biotechnology company specializing in gene therapies aimed at restoring, improving, and preserving hearing for individuals with inner ear disorders.
Sector
Biotech
AI Layer
Non-AI
Keywords
adeno-associated viral (AAV) gene therapygene therapy for sensorineural hearing lossprecision genetic medicine for hearinggene therapy for OTOF-mediated hearing lossdual AAV vector-based gene therapygene delivery to inner ear hair cellsinner ear gene therapiesgene therapy for Usher Syndrome Type 3Agene therapy for vestibular schwannomagene therapy for monogenic deafness
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Akouos Comps
Public and private peers based on sector, stage, and business model.
Akouos Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Oct 18, 2022 | ||||
| IPO Announced | Jun 30, 2020 | ||||
| Series B | Feb 27, 2020 | ||||
| Series A | Aug 7, 2018 | ||||
| Seed | Nov 30, 2017 |
Akouos Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EcoR1 Capital | Series B |
| RA Capital Management | Series A, Series B |
| New Enterprise Associates (NEA) | Series B, Seed, Series A |
| Mass General Brigham Innovation | Seed, Series A, Series B |
| Fidelity Management & Research Company | Series B |
| TD Securities | Series B |
| Blue Owl Capital | Series B |
Akouos Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Firmographic Details
HeadquartersBoston, Massachusetts
Employee Range49
Year Founded2016
Last FundingOct 18, 2022
